ProPhase Labs, Inc. (ticker: PRPH) is an OTC-listed pharmaceutical preparations company. DredgeCap's structured extraction of PRPH's SEC filings surfaces 14 active risk signals, including 10 late-filing signals, 2 auditor-change signals, and 2 delisting/deregistration signals. PRPH reported $3.56M in revenue and -$7.34M for the period ending 2025-09-30, with operating cash flow of -$7.11M. Cash and equivalents stood at $405K (down 19.2% year-over-year). Total assets of $65.70M exceed total liabilities of $58.84M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
PRPH Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for ProPhase Labs, Inc. (PRPH) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.